Goal
To treat cancer by delivering an oxidizing solution (chlorine equivalent) that reverses cellular hypoxia and normalizes DNA replication.
Problem
Cancerous tumors and associated hypoxia-induced cellular damage.
Concept Summary
The invention describes the preparation of physiological saline that has been electrolyzed to generate a solution containing approximately 65 ppm of active oxidants-primarily hypochlorite, with smaller amounts of ozone and free radicals-collectively termed "chlorine equivalent". When administered intravenously or intramuscularly, the solution is claimed to act as a supplemental oxidant, alleviating cellular hypoxia, correcting chemical imbalances, and thereby causing rapid regression of malignant tissue.
Detailed Description
The method involves passing an electric current (3.5-7 V) through a sodium-chloride brine (physiological saline) to produce hypochlorite, ozone, and free radicals. The resulting solution is injected directly into or around tumors, or administered systemically via IV infusion. Reported clinical observations include tumor shrinkage within 48-72 hours, remission of advanced cancers, and extended survival in case patients. The author attributes the therapeutic effect to oxidation-mediated reversal of hypoxia and restoration of normal DNA replication processes.
Principles
- Oxidative therapy
- Hypoxia reversal
- Bioelectrolysis
- Chlorine-based oxidants
Scientific Domains
Materials
- Physiological saline
- Sodium chloride
- Hypochlorite
- Ozone
- Free radicals
Mechanisms of Action
- Oxidation of cellular components
- Mitigation of cellular hypoxia
- Normalization of DNA replication
Energy Sources
Applications
- Cancer therapy
- Wound healing
- Antimicrobial disinfection
Claimed Performance
Rapid tumor regression (48-72 h), disappearance of isolated tumors, restoration of normal tissue, and survival extension up to 71/2 months in advanced cancer patients.
Experimental Evidence
Multiple case histories are described: (1) a patient with extensive upper-body malignancy showed tumor retreat after local IM injections and disappearance of isolated tumors within 48 h; (2) a comparative anecdote where a treated patient survived 71/2 months versus an untreated control who died within a week; (3) early-stage lip cancer resolved after three IV injections (750 cc) over two weeks, with no tumor detectable after one month.
Replication Status
No controlled or replicated studies are reported; evidence consists of anecdotal case histories.
Limitations
- Lack of controlled clinical trials
- Potential toxicity of chlorine/ozone at high doses
- Unclear optimal dosing and administration protocol
Red Flags
- Claims are based on anecdotal case reports rather than peer-reviewed studies
- No regulatory approval for medical use
- Potential for misuse or over-dosage of oxidizing agents
